Global Irritable Bowel Syndrome (IBS) Research Report 2017-2022
This report studies the Irritable Bowel Syndrome market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Irritable Bowel Syndrome market by product type and applications/end industries.
The major players in global Irritable Bowel Syndrome market include
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Irritable Bowel Syndrome in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Japan
RoW
On the basis of product, the Irritable Bowel Syndrome market is primarily split into
IBS-D Drug
IBS-C Drug
Other
On the basis on the end users/applications, this report covers
Women
Men
The major players in global Irritable Bowel Syndrome market include
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Irritable Bowel Syndrome in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Japan
RoW
On the basis of product, the Irritable Bowel Syndrome market is primarily split into
IBS-D Drug
IBS-C Drug
Other
On the basis on the end users/applications, this report covers
Women
Men
1 IRRITABLE BOWEL SYNDROME MARKET OVERVIEW
1.1 Product Overview and Scope of Irritable Bowel Syndrome
1.2 Irritable Bowel Syndrome Segment by Types (Product Category)
1.2.1 Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (Product Category) (2016-2022)
1.2.2 Global Irritable Bowel Syndrome Market Share (%) by Types (Product Category) in 2016
1.2.3 IBS-D Drug
1.2.4 IBS-C Drug
1.2.5 Other
1.3 Global Irritable Bowel Syndrome Segment by Applications
1.3.1 Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022)
1.3.2 Women
1.3.3 Men
1.4 Global Irritable Bowel Syndrome Market by Regions (2012-2022)
1.4.1 Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022)
1.4.2 North America Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.3 Japan Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.4 Europe Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.5 RoW Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.5 Global Irritable Bowel Syndrome Market Size (2012-2022)
2 GLOBAL IRRITABLE BOWEL SYNDROME MARKET COMPETITION BY MANUFACTURERS
2.1 Global Irritable Bowel Syndrome Revenue and Market Share by Manufacturers (2016-2017)
2.2 Global Irritable Bowel Syndrome Gross Margin by Manufacturers (2016-2017)
2.3 Manufacturers Irritable Bowel Syndrome Headquarter, Sales Area, Product Types
2.4 Irritable Bowel Syndrome Market Competitive Situation and Trends
2.4.1 Irritable Bowel Syndrome Market Concentration Rate
2.4.2 Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 and Top 5 Manufacturers in 2016
2.4.3 Mergers & Acquisitions, Expansion
3 GLOBAL IRRITABLE BOWEL SYNDROME REVENUE BY REGIONS (2012-2017)
3.1 Global Irritable Bowel Syndrome Revenue and Market Share (%) by Regions (2012-2017)
3.2 Global Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017)
3.3 North America Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017)
3.4 Europe Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
3.5 Japan Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
3.6 RoW Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL IRRITABLE BOWEL SYNDROME REVENUE SIZE BY TYPES
4.1 Global Irritable Bowel Syndrome Revenue and Market Share by Types (2012-2017)
4.2 Global Irritable Bowel Syndrome Growth by Type (2012-2017)
5 GLOBAL IRRITABLE BOWEL SYNDROME MARKET ANALYSIS BY APPLICATIONS
5.1 Global Irritable Bowel Syndrome Sales and Market Share by Applications (2012-2017)
5.2 Global Irritable Bowel Syndrome Sales Growth Rate by Applications (2012-2017)
6 GLOBAL IRRITABLE BOWEL SYNDROME MANUFACTURERS PROFILES/ANALYSIS
6.1 Allergan
6.1.1 Company Basic Information, Key Products and Sales Area
6.1.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.1.3 Allergan Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.2 Valeant Pharmaceuticals
6.2.1 Company Basic Information, Key Products and Sales Area
6.2.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.3 Takeda
6.3.1 Company Basic Information, Key Products and Sales Area
6.3.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.3.3 Takeda Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.4 Sucampo Pharmaceuticals
6.4.1 Company Basic Information, Key Products and Sales Area
6.4.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.5 McNeil Consumer Healthcare
6.5.1 Company Basic Information, Key Products and Sales Area
6.5.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.6 Sebela Pharmaceuticals
6.6.1 Company Basic Information, Key Products and Sales Area
6.6.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.7 Astellas Pharmaceuticals
6.7.1 Company Basic Information, Key Products and Sales Area
6.7.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.8 IM HealthScience
6.8.1 Company Basic Information, Key Products and Sales Area
6.8.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.8.3 IM HealthScience Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
7 IRRITABLE BOWEL SYNDROME MANUFACTURING COST ANALYSIS
7.1 Irritable Bowel Syndrome R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.1.3 United States Irritable Bowel Syndrome Medical Cost
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Irritable Bowel Syndrome Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Irritable Bowel Syndrome Facts and Dynamic
10.1.1 FDA Approves Two Therapies to Treat IBS-D in 2015
10.1.2 Irritable Bowel Syndrome Facts
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 GLOBAL IRRITABLE BOWEL SYNDROME MARKET FORECAST (2017-2022)
11.1 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast (2017-2022)
11.2 Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022)
11.2.1 North America Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.2 Europe Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.3 Japan Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.4 RoW Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.3 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast by Type (2017-2022)
11.4 Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1.1 Product Overview and Scope of Irritable Bowel Syndrome
1.2 Irritable Bowel Syndrome Segment by Types (Product Category)
1.2.1 Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (Product Category) (2016-2022)
1.2.2 Global Irritable Bowel Syndrome Market Share (%) by Types (Product Category) in 2016
1.2.3 IBS-D Drug
1.2.4 IBS-C Drug
1.2.5 Other
1.3 Global Irritable Bowel Syndrome Segment by Applications
1.3.1 Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022)
1.3.2 Women
1.3.3 Men
1.4 Global Irritable Bowel Syndrome Market by Regions (2012-2022)
1.4.1 Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022)
1.4.2 North America Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.3 Japan Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.4 Europe Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.4.5 RoW Irritable Bowel Syndrome Status and Prospect (2012-2022)
1.5 Global Irritable Bowel Syndrome Market Size (2012-2022)
2 GLOBAL IRRITABLE BOWEL SYNDROME MARKET COMPETITION BY MANUFACTURERS
2.1 Global Irritable Bowel Syndrome Revenue and Market Share by Manufacturers (2016-2017)
2.2 Global Irritable Bowel Syndrome Gross Margin by Manufacturers (2016-2017)
2.3 Manufacturers Irritable Bowel Syndrome Headquarter, Sales Area, Product Types
2.4 Irritable Bowel Syndrome Market Competitive Situation and Trends
2.4.1 Irritable Bowel Syndrome Market Concentration Rate
2.4.2 Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 and Top 5 Manufacturers in 2016
2.4.3 Mergers & Acquisitions, Expansion
3 GLOBAL IRRITABLE BOWEL SYNDROME REVENUE BY REGIONS (2012-2017)
3.1 Global Irritable Bowel Syndrome Revenue and Market Share (%) by Regions (2012-2017)
3.2 Global Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017)
3.3 North America Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017)
3.4 Europe Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
3.5 Japan Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
3.6 RoW Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017)
4 GLOBAL IRRITABLE BOWEL SYNDROME REVENUE SIZE BY TYPES
4.1 Global Irritable Bowel Syndrome Revenue and Market Share by Types (2012-2017)
4.2 Global Irritable Bowel Syndrome Growth by Type (2012-2017)
5 GLOBAL IRRITABLE BOWEL SYNDROME MARKET ANALYSIS BY APPLICATIONS
5.1 Global Irritable Bowel Syndrome Sales and Market Share by Applications (2012-2017)
5.2 Global Irritable Bowel Syndrome Sales Growth Rate by Applications (2012-2017)
6 GLOBAL IRRITABLE BOWEL SYNDROME MANUFACTURERS PROFILES/ANALYSIS
6.1 Allergan
6.1.1 Company Basic Information, Key Products and Sales Area
6.1.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.1.3 Allergan Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.2 Valeant Pharmaceuticals
6.2.1 Company Basic Information, Key Products and Sales Area
6.2.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.3 Takeda
6.3.1 Company Basic Information, Key Products and Sales Area
6.3.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.3.3 Takeda Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.4 Sucampo Pharmaceuticals
6.4.1 Company Basic Information, Key Products and Sales Area
6.4.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.5 McNeil Consumer Healthcare
6.5.1 Company Basic Information, Key Products and Sales Area
6.5.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.6 Sebela Pharmaceuticals
6.6.1 Company Basic Information, Key Products and Sales Area
6.6.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.7 Astellas Pharmaceuticals
6.7.1 Company Basic Information, Key Products and Sales Area
6.7.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
6.8 IM HealthScience
6.8.1 Company Basic Information, Key Products and Sales Area
6.8.2 Irritable Bowel Syndrome Product Category, Application and Specification
6.8.3 IM HealthScience Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017)
7 IRRITABLE BOWEL SYNDROME MANUFACTURING COST ANALYSIS
7.1 Irritable Bowel Syndrome R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.1.3 United States Irritable Bowel Syndrome Medical Cost
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Irritable Bowel Syndrome Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Irritable Bowel Syndrome Facts and Dynamic
10.1.1 FDA Approves Two Therapies to Treat IBS-D in 2015
10.1.2 Irritable Bowel Syndrome Facts
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 GLOBAL IRRITABLE BOWEL SYNDROME MARKET FORECAST (2017-2022)
11.1 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast (2017-2022)
11.2 Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022)
11.2.1 North America Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.2 Europe Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.3 Japan Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.2.4 RoW Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022)
11.3 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast by Type (2017-2022)
11.4 Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022)
12 RESEARCH FINDINGS AND CONCLUSION
13 METHODOLOGY AND DATA SOURCE
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of Irritable Bowel Syndrome
Table Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (2016-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Types (Product Category) in 2016
Table Irritable Bowel Syndrome Type and Characteristic
Figure Product Picture of IBS-D Drug
Figure Product Picture of IBS-C Drug
Figure Product Picture of Other
Table Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016
Table IBS Symptoms in Men and Women
Figure Women Examples
Figure Men Examples
Figure Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022)
Figure North America Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Japan Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Europe Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure RoW Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Global Irritable Bowel Syndrome Revenue (M USD) Status and Outlook (2012-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) by Manufacturers (2016-2017)
Table Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers (2016-2017)
Figure 2016 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers
Figure 2017 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers
Table Global Market Irritable Bowel Syndrome Gross Margin) of Key Manufacturers (2016-2017)
Figure Global Market Irritable Bowel Syndrome Gross Margin of Key Manufacturers in 2016
Table Manufacturers Irritable Bowel Syndrome Headquarter and Sales Area
Table Manufacturers Irritable Bowel Syndrome Product Category
Figure Irritable Bowel Syndrome Market Concentration Rate in 2016
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 Manufacturers in 2016
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 5 Manufacturers in 2016
Table Mergers & Acquisitions, Expansion News
Table Global Irritable Bowel Syndrome Revenue (M USD) by Regions (2012-2017)
Table Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions
Figure 2017 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions
Figure Global Irritable Bowel Syndrome Revenue and Growth Rate (%) (2012-2017)
Table Global Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table North America Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Europe Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Japan Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table RoW Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Global Irritable Bowel Syndrome Revenue (M USD) by Types (2012-2017)
Table Global Irritable Bowel Syndrome Revenue Share (%) by Types (2012-2017)
Figure Revenue Share (%) Irritable Bowel Syndrome by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Irritable Bowel Syndrome by Types
Table Global Irritable Bowel Syndrome Growth by Type (2012-2017)
Figure Global Irritable Bowel Syndrome Growth by Type (2012-2017)
Table Global Irritable Bowel Syndrome Sales by Applications (2012-2017)
Table Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016
Table Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Allergan Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Valeant Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Takeda Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Takeda Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Sucampo Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table McNeil Consumer Healthcare Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Sebela Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Astellas Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table IM HealthScience Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table IM HealthScience Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Irritable Bowel Syndrome Compound
Table Capitalized Preclinical and Clinical Period Costs per Investigational Irritable Bowel Syndrome Compound
Table Manufacturing Cost Structure of Irritable Bowel Syndrome
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016
Figure 2016 Global Manufacturing Competitiveness Index rankings by country
Figure US Nonfarm Unit Labor Cost 2014-2016
Figure USA Average Hourly Wages (USD/H) 2016-2017
Figure China Labor Cost Index 2014-2016
Figure China Average Yearly Wages 2006-2016
Figure Euro Area Labor Cost 2014-2016
Table Gross Margin of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Irritable Bowel Syndrome Industrial Chain Analysis
Table Major Buyers of Irritable Bowel Syndrome
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure IBS Causes, Changes, Triggers and Symptoms
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2016-2017
Figure Japan CPI Change 2012-2016
Figure Japan GDP 2006-2016 (Billion USD)
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Global Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure RoW Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type in 2022
Table Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022)
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Application (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Forecast by Application (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Forecast by Application in 2022
Figure Product Picture of Irritable Bowel Syndrome
Table Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (2016-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Types (Product Category) in 2016
Table Irritable Bowel Syndrome Type and Characteristic
Figure Product Picture of IBS-D Drug
Figure Product Picture of IBS-C Drug
Figure Product Picture of Other
Table Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016
Table IBS Symptoms in Men and Women
Figure Women Examples
Figure Men Examples
Figure Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022)
Figure North America Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Japan Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Europe Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure RoW Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Global Irritable Bowel Syndrome Revenue (M USD) Status and Outlook (2012-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) by Manufacturers (2016-2017)
Table Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers (2016-2017)
Figure 2016 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers
Figure 2017 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers
Table Global Market Irritable Bowel Syndrome Gross Margin) of Key Manufacturers (2016-2017)
Figure Global Market Irritable Bowel Syndrome Gross Margin of Key Manufacturers in 2016
Table Manufacturers Irritable Bowel Syndrome Headquarter and Sales Area
Table Manufacturers Irritable Bowel Syndrome Product Category
Figure Irritable Bowel Syndrome Market Concentration Rate in 2016
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 Manufacturers in 2016
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 5 Manufacturers in 2016
Table Mergers & Acquisitions, Expansion News
Table Global Irritable Bowel Syndrome Revenue (M USD) by Regions (2012-2017)
Table Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions
Figure 2017 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions
Figure Global Irritable Bowel Syndrome Revenue and Growth Rate (%) (2012-2017)
Table Global Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table North America Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Europe Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Japan Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table RoW Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017)
Table Global Irritable Bowel Syndrome Revenue (M USD) by Types (2012-2017)
Table Global Irritable Bowel Syndrome Revenue Share (%) by Types (2012-2017)
Figure Revenue Share (%) Irritable Bowel Syndrome by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Irritable Bowel Syndrome by Types
Table Global Irritable Bowel Syndrome Growth by Type (2012-2017)
Figure Global Irritable Bowel Syndrome Growth by Type (2012-2017)
Table Global Irritable Bowel Syndrome Sales by Applications (2012-2017)
Table Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016
Table Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Allergan Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Valeant Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Takeda Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Takeda Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Sucampo Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table McNeil Consumer Healthcare Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Sebela Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table Astellas Pharmaceuticals Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Table IM HealthScience Basic Information, Key Products and Sales Area
Table Irritable Bowel Syndrome Product Category, Application and Specification
Table IM HealthScience Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017)
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Irritable Bowel Syndrome Compound
Table Capitalized Preclinical and Clinical Period Costs per Investigational Irritable Bowel Syndrome Compound
Table Manufacturing Cost Structure of Irritable Bowel Syndrome
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016
Figure 2016 Global Manufacturing Competitiveness Index rankings by country
Figure US Nonfarm Unit Labor Cost 2014-2016
Figure USA Average Hourly Wages (USD/H) 2016-2017
Figure China Labor Cost Index 2014-2016
Figure China Average Yearly Wages 2006-2016
Figure Euro Area Labor Cost 2014-2016
Table Gross Margin of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Irritable Bowel Syndrome Industrial Chain Analysis
Table Major Buyers of Irritable Bowel Syndrome
Figure Setting Pricing Policy
Table Distributors/Traders List
Figure IBS Causes, Changes, Triggers and Symptoms
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2016-2017
Figure Japan CPI Change 2012-2016
Figure Japan GDP 2006-2016 (Billion USD)
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure Global Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Figure RoW Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type in 2022
Table Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022)
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Application (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Forecast by Application (2017-2022)
Figure Global Irritable Bowel Syndrome Sales Forecast by Application in 2022
